40 - Pulmonary Medchem Flashcards

1
Q

What Pulmonary Drug Class?

DILATION of Bronchial Passages
Vasodilation in muscle + Liver
Relaxation of uterine muscle // release of insulin
by
AGONISING –>
SYMPATHETIC/Adrenergic Receptors

A
  • *BETA-ADRENERGIC AGONISTS**
  • *-TEROL** / -TERENOL / Terbutaline
  • *B2: Relaxes**

A1: Contracts minor

FROM:
EPINEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Beta-Adrenergic Agents

Originate from what Endogenous Compound?

A
  • *CATECHOLAMINES**
  • *Epinephrine / Norepinephrine**

Only the R** **enantiomer = ACTIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3-point interactions for RECEPTOR BINDING

A

EPINEPHRINE

1) Para/Meta -OH

2) Beta -OH

3) -NHR

Metabolism:
MAO / COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta-Adrenergic Agent Parent Structure:

What is ESSENTIAL for BINDING?

A
  • *1*_ or _2***
  • *AMINO GROUP**

seperated by:
TWO CARBONS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Beta-Adrenergic Agent Parent Structure:

What INCREASES BETA-2 SELECTIVITY?

A
  • *BULKY N-SUBSTITUENT**
  • *N-Tertiary Butyl**

or

Aromatic MethylHydroxy Substitution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Beta-Adrenergic Agent Parent Structure:

What give PROTECTION from MAO?

A

LARGER AMINO SUBSTITUENT

  • *Alpha Carbon Sub**
  • but also decreases alpha/beta activity*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Beta-Adrenergic Agent Parent Structure:

What does a
ALPHA-CARBON SUBSTITUTION

do?

A
  • DECREASED*
  • *Alpha + Beta Activity**
  • BUT*:
  • *MAO PROTECTION**
  • *= longer DOA (drug action) & Oral Bioavailability**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Beta-Adrenergic Agent Parent Structure:

What does the replacement of… do?

CATECHOL –> RESORCINOL

A

Protection from COMT

oral BioAvailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What Drug?

A
  • *ISOPROTERENOL**
  • *Short-Acting B-adrenergic Agonist**

Catechol - Based

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Isoproterenol

Drug Type / Metabolism / Disadvantages

A

SHORT ACTING - B2 Adrenergic Agent
Catechol-based

Most POTENT** **bronchodialator

Oxidation Labile –> BENZOCHINONE

  • Disadvantages:*
  • *Cardiac ADR** = NOT B2 specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which Drug?

A

ALBUTEROL** / **SALBUTAMOL
SHORT-ACTING
- B2 Adrenergic Agents

N-Tertiary Butyl –> B2 Selectivity

Aromatic MethylHydroxy Substitution –> B2 Selectivity

Alpha Substitution –> MAO Protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What Drug?

A
  • *TERBUTALINE**
  • *Short-Acting B2 Adrenergic Agonist**

Resocinol Based = No COMT Metabolism

N-Tertiary Butyl = ↑B2 Selectivity

  • *Alpha Substitution = MAO PROTECTION**
  • decreased Alpha&Beta Selectivity*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What Drug?

A
  • *METAPROTERENOL**
  • *Short-Acting B2 Adrenergic Agonist**

Resocinol Based = No COMT Metabolism

  • *Alpha Substitution = MAO PROTECTION
  • decreased Alpha&Beta Selectivity***
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the SHORT ACTING

Beta-Adrenergic Agonists?

A
  • *Isoproterenol**
    0. 5-2 hours

Metaproterenol
3-4 hours

Tertbutaline / Pirbuterol
B2>B1 selectivity, 4-8 hours

Albuterol / Levalbuterol / Salbutamol
B2>B1 selectivity, 4-8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the LONG ACTING
Beta Adrenergic Agonists?

A

All orally active –> not metabolized by BOTH COMT nor MAO
>12 hours

Salmeterol
long lipophylic side chain

Formoterol
prodrug

Bambuterol
prodrug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the ULTRA LONG ACTING
Beta-Adrenergic Agents?

A

INDACATEROL
Racemate, >24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What Drug?

A
  • *SALMETEROL**
  • *Long-Acting Beta Adrenergic Agonist**

Long Lipophlic Side Chain
racemate

Orally active –> NOT metabolized with MAO nor COMT

18
Q

What Drug?

A
  • *Formoterol / Bambuterol**
  • *Long-Acting Beta Adrenergic Agonist**

BOTH PRODRUGE
Racemate

Orally active –> NOT metabolized with MAO nor COMT

19
Q

What Drug?

A

EPINEPHRINE
(R) = Norepinephrine

  • NON-SELECTIVE B-adrenergic AGONIST*
  • LEAST SELECTIVE*
  • *Used for Allergic Reactions**
  • *Fast action = half life = 2min**
20
Q

Which Pulmonary Drug Class?

*ANTAGONIZES* –> M3 RECEPTOR
VVV
cGMP
VVV
DILATE Bronchoconstrictor Muscles
Mucus Secetion
VVV
Dilation of Bronchial Passages

A

ANTICHOLINERGICS** = **ANTIMUSCARINIC
BronchoDilator

Tiotropium = LA

Ipatropium = Short Acting

Atropine + Scopolamine

21
Q

What Drugs?

A

Atropine** + **Scopolamine

  • *Anticholinergics = Antimuscarinics**
  • Similar to ACETYLCHOLINE = ACh*

Naturally occuring TROPINE ALKALOIDS

22
Q

Wuz dis?

A

TROPANE

Nitrogenous Bi-Cyclic Compound

hydroxylated –> Tropine

Atropine / Scopolamine
Anticholinergics = Antimuscarinics

23
Q

Wuz Dis?

A

TROPINE

Hydroxylated TROPANE

Esters of TROPINE = Atropine + Scopolamine

24
Q

What Drug?

A
  • *IPATROPIUM**
  • SHORT-ACTING* Anticholinergic

Phenyl Ring = More Likely to be Oxygenated
SHORT ACTING

does NOT diffuse into the BLOOD –> no SYSTEMIC ADRs

  • *QUATENARY AMINE**
  • -> does NOT cross the BBB = no AC ADRs

NON-SELECTIVE Antimuscarinic –> but ONLY M3 in the LUNGS

25
Q

What Drug?

A
  • *TIOTROPIUM**
  • *LONG-ACTING Anticholinergic**

does NOT diffuse into the BLOOD –> no SYSTEMIC ADRs

  • *QUATENARY AMINE**
  • -> does NOT cross the BBB = no AC ADRs

NON-SELECTIVE Antimuscarinic –> but ONLY M3 in the LUNGS

26
Q

What is ESSENTIAL for

ANTICHOLINERGIC ANTAGONIST = Antimuscarinic

Tiotropium / Ipatropium

A

R1** **needs to point BACKWARDS

27
Q

What makes 3 things make an

AntiCholinergic Antigonist

MOST POTENT?

A
  • *R1** = AROMATIC
  • -> VanderWals w receptor
  • *R2 = HYDROPHOBIC RING**
  • limited size*

R3 = HYDROGEN BONDING

28
Q

Which Drug type?

  • Reduce:*
  • *inflammation in airways**
  • *Lung Damage & airway narrowing** from inflammation
  • *Mucus Production**
A

CORTICOSTEROIDS
Based from Cortisol

Expression of B2 Receptors

Upregulates expression of LIPOCORTIN-1
–> ↓supresses Phospholipase A2

Expression of Pro-Inflammatory Proteins / Cytokines
↓Prostaglandins & Leukotrienes

Supresses Cyclo-Oxygenase Expression

29
Q

What MoA of CORTICOSTEROIDS

are INCREASING / UPREGULATING?

A

Expression of B2 Receptors

Upregulates expression of LIPOCORTIN-1
–> ↓supresses Phospholipase A2

30
Q

What MoA of CORTICOSTEROIDS

are SUPRESSING / REDUCING?

A
  • ↑Upregulates expression of LIPOCORTIN-1*
  • -> ↓supresses Phospholipase A2

Expression of Pro-Inflammatory Proteins / Cytokines

↓Prostaglandins & Leukotrienes

Supresses Cyclo-Oxygenase Expression

31
Q

Given that CORTICOSTEROIDS

  • *do NOT act DIRECTLY on the AIRWAY SMOOTH MUSCLE**
  • do NOT provide immediate relief*

WHY ARE THEY INHALED?

A

AVOIDS FIRST PASS METABOLISM
so we can use lower doses –> systemic absorption

32
Q

What type of Drug?

A

ORAL = SYSTEMIC CORTICOSTEROIDS
Anti-Inflammatory Agents

33
Q

What TYPE of drug?

A

INHALED CORTICOSTEROIDS

34
Q

Which Leukotriene Modifier?

Blocks the SYNTHESIS of Leukotriens?

A

ZILEUTON

Inhibits 5-LIPOXYGENASE

other 2 drugs just block the BINDING

35
Q

What drug type?

Inhibition of _______
VV
Reduction of Bronchoconstriction & Inflammation

less effective vs Corticosteroids
w/ less side effects

A

LEUKOTRINE MODIFIERS

Montelukast / Zafirlukast

  • *LTRA = Leukotriene Receptor Antagonist**
  • Block action of Leukotriene on the Leukotriene Receptor*
  • *Zileuton**
  • *Inhibitor of 5-Lipoxygenase**
36
Q

What drug?

A
  • *ZAFIRLUKAST**
  • *Leukotrine Receptor Antagonist** = LTRA –> Anti-Inflammatory Agent

Blocks the action of:
Leukotriene on the Leukotriene Receptor
@ lungs & bronchial tubes, by BINDING to it

37
Q

What drug?

A
  • *MONTELUKAST**
  • *Leukotrine Receptor Antagonist** = LTRA –> Anti-Inflammatory Agent

Blocks the action of:
Leukotriene D4 on the Leukotriene Receptor
@ lungs & bronchial tubes, by BINDING to it

38
Q

What Drug? & MoA?

A
  • *THEOPHYLLINE**
  • *Methylxanthine**

Relaxing effect on Bronchial Smooth Muscle:
Competitive NON-selective PD-4 INHIBITOR
VV
inhibits Leukotriene Synthesis –> Reduces Inflammation

39
Q

Which Drug Type?

Prevent & Control ALLERGIC Disorders

Blocking of: Calcium Channels essential for
Mast-Cell Degranulation & Cell Stabilization
VVV
Prevent release of HISTAMINE + Related Mediators

A
  • *MAST CELL STABILIZERS**
  • *Chromolyn (Nedocromil) / Chromone**

without intracellular CALCIUM
VV
histamine vesicles CAN’T fuse to the cell membrane & degranulate

40
Q

Omalizumab = Xolair

Indication / ADR / MoA

A

For patients with:

  • *Severe / Persistant ALLERGIC ASTHMA**
  • that is not controlled with HIGH doses of Corticosteroids*
  • CAUSES ANAPHYLAXIS*
  • does NOT work immediately –> not for ACUTE*
  • *SUBQ Inj Q2-4Weeks**

BINDS TO IgE** –> **prevents CROSSLINKING